Brief: ImmuCell Q4 Loss Per Share $0.04
19/02/2020 17:48
Feb 19 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE
YEAR
ENDED DECEMBER 31, 2019
* Q4 LOSS PER SHARE $0.04
* IMMUCELL - TOTAL PRODUCT SALES INCREASED BY $2.74 MILLION
OR
25%, TO $13.7 MILLION DURING YEAR ENDED DECEMBER 31, 2019 VERSUS
YEAR ENDED DECEMBER 31, 2018
Source text for Eikon: ID:nGNXFzf39
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year